Panacea Innovation Ltd - 17 Jul 2025 Form 4 Insider Report for Atara Biotherapeutics, Inc. (ATRA)

Role
10%+ Owner
Signature
Panacea Innovation Limited By: /s/ James Huang, Founding Managing Partner
Issuer symbol
ATRA
Transactions as of
17 Jul 2025
Net transactions value
+$186,372
Form type
4
Filing time
21 Jul 2025, 09:00:05 UTC
Previous filing
21 May 2025
Next filing
19 Aug 2025

Reporting Owners (2)

Name Relationship Address Signature Signature date CIK
Panacea Innovation Ltd 10%+ Owner C/O MAPLES CORPORATE SERVICES LIMITED,, UGLAND HOUSE, GRAND CAYMAN, CAYMAN ISLANDS Panacea Innovation Limited By: /s/ James Huang, Founding Managing Partner 21 Jul 2025 0002010692
Huang James Director, 10%+ Owner C/O MAPLES CORPORATE SERVICES LIMITED,, UGLAND HOUSE, GRAND CAYMAN, CAYMAN ISLANDS /s/ James Huang 21 Jul 2025 0001573160

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATRA Common Stock Purchase $186,372 +19,335 +1.5% $9.64 1,350,000 17 Jul 2025 See Footnotes F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents securities held by Panacea Venture Healthcare Fund II, L.P.
F2 James Huang is the sole owner of Panacea Innovation Limited, which is the sole owner of Panacea Venture Healthcare Fund II GP Company, Ltd. ("Fund II GP") and Panacea Opportunity Fund I GP Company, Ltd. ("Opportunity Fund GP"), which are the general partners of Panacea Venture Healthcare Fund II, L.P. and Panacea Opportunity Fund I, L.P. As a result, each of the Reporting Persons may be deemed to share beneficial ownership of the securities held of record by Panacea Venture Healthcare Fund II, L.P. and Panacea Opportunity Fund I, L.P., but each disclaims such beneficial ownership.